Mangoceuticals (MGRX) Competitors $1.85 +0.01 (+0.49%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGRX vs. CCM, MRAI, BGLC, BRTX, SSY, DHAC, ACON, ATIP, NIVF, and OTRKShould you be buying Mangoceuticals stock or one of its competitors? The main competitors of Mangoceuticals include Concord Medical Services (CCM), Marpai (MRAI), BioNexus Gene Lab (BGLC), Biorestorative Therapies (BRTX), SunLink Health Systems (SSY), Digital Health Acquisition (DHAC), Aclarion (ACON), ATI Physical Therapy (ATIP), NewGenIvf Group (NIVF), and Ontrak (OTRK). These companies are all part of the "healthcare" industry. Mangoceuticals vs. Its Competitors Concord Medical Services Marpai BioNexus Gene Lab Biorestorative Therapies SunLink Health Systems Digital Health Acquisition Aclarion ATI Physical Therapy NewGenIvf Group Ontrak Mangoceuticals (NASDAQ:MGRX) and Concord Medical Services (NYSE:CCM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment. Do institutionals and insiders have more ownership in MGRX or CCM? 56.7% of Mangoceuticals shares are owned by institutional investors. 16.0% of Mangoceuticals shares are owned by insiders. Comparatively, 46.5% of Concord Medical Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media favor MGRX or CCM? In the previous week, Mangoceuticals had 1 more articles in the media than Concord Medical Services. MarketBeat recorded 1 mentions for Mangoceuticals and 0 mentions for Concord Medical Services. Mangoceuticals' average media sentiment score of 1.53 beat Concord Medical Services' score of 0.00 indicating that Mangoceuticals is being referred to more favorably in the media. Company Overall Sentiment Mangoceuticals Very Positive Concord Medical Services Neutral Which has better earnings & valuation, MGRX or CCM? Mangoceuticals has higher earnings, but lower revenue than Concord Medical Services. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMangoceuticals$511.08K18.81-$8.71M-$4.64-0.40Concord Medical Services$52.60M0.42-$42.23MN/AN/A Is MGRX or CCM more profitable? Concord Medical Services has a net margin of 0.00% compared to Mangoceuticals' net margin of -2,191.76%. Concord Medical Services' return on equity of 0.00% beat Mangoceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Mangoceuticals-2,191.76% -72.81% -66.58% Concord Medical Services N/A N/A N/A Which has more volatility and risk, MGRX or CCM? Mangoceuticals has a beta of 2.42, suggesting that its share price is 142% more volatile than the S&P 500. Comparatively, Concord Medical Services has a beta of -0.94, suggesting that its share price is 194% less volatile than the S&P 500. SummaryMangoceuticals beats Concord Medical Services on 6 of the 11 factors compared between the two stocks. Get Mangoceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MGRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGRX vs. The Competition Export to ExcelMetricMangoceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.61M$2.41B$5.45B$9.67BDividend YieldN/A1.78%3.99%4.14%P/E Ratio-0.4020.1830.0425.01Price / Sales18.81442.70377.6078.24Price / CashN/A165.0335.9458.58Price / Book0.434.128.135.68Net Income-$8.71M$31.61M$3.25B$265.58M7 Day Performance8.77%0.29%1.09%2.50%1 Month Performance20.78%2.27%2.75%1.87%1 Year Performance-97.75%4.42%28.40%24.05% Mangoceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGRXMangoceuticals0.991 of 5 stars$1.86+1.1%N/A-97.8%$9.61M$511.08K-0.403Positive NewsUpcoming EarningsCCMConcord Medical ServicesN/A$5.05-5.4%N/A-34.9%$23.18M$52.60M0.00970Gap UpMRAIMarpaiN/A$1.34-0.7%N/A+158.8%$22.33M$34.87M-0.51150News CoverageBGLCBioNexus Gene Lab0.1463 of 5 stars$5.73-13.7%N/A+29.8%$11.93M$9.51M0.0030Negative NewsUpcoming EarningsBRTXBiorestorative Therapies3.0502 of 5 stars$1.49+0.7%$18.00+1,108.1%+8.3%$11.11M$400K0.007Upcoming EarningsSSYSunLink Health Systems1.134 of 5 stars$1.02-8.9%N/A+30.9%$7.18M$31.09M7.291,376High Trading VolumeDHACDigital Health AcquisitionN/A$1.39+14.9%N/A-62.6%$5.01MN/A0.002,021Gap UpHigh Trading VolumeACONAclarion1.992 of 5 stars$7.40+5.7%$11,758.50+158,798.6%-99.7%$4.08M$50K0.007Positive NewsUpcoming EarningsATIPATI Physical Therapy0.1093 of 5 stars$0.68flatN/A-89.0%$2.98M$741.86M-0.045,600Gap UpNIVFNewGenIvf GroupN/A$2.24-5.1%N/A-99.8%$2.04M$5.43M0.00N/AGap DownOTRKOntrak2.104 of 5 stars$0.39+40.1%$24.00+6,117.6%-88.9%$1.16M$10.85M-0.02250News CoverageShort Interest ↑High Trading Volume Related Companies and Tools Related Companies CCM Alternatives MRAI Alternatives BGLC Alternatives BRTX Alternatives SSY Alternatives DHAC Alternatives ACON Alternatives ATIP Alternatives NIVF Alternatives OTRK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGRX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mangoceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mangoceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MGRX Stock Alerts